Presentatie - vzw farmaka asbl
Presentatie - vzw farmaka asbl
Presentatie - vzw farmaka asbl
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
β-blokkers<br />
Gami P. Secondary prevention of ischaemic cardiac events. Clinical Evidence 2007.<br />
Design N/n Population Sd Interventions Outcomes Results<br />
MA<br />
(search<br />
date<br />
1993)<br />
N=27,<br />
n>24000<br />
Days / weeks after acute<br />
MI<br />
6 w to 3 y<br />
(mostly 1 y)<br />
-β-blockers<br />
-Placebo<br />
Mortality RR= 0.77 (95% CI 0.70<br />
to 0.86) in favour of β-<br />
blockers<br />
1.Gami P. Secondary prevention of ischaemic cardiac events. Clinical Evidence 2003.<br />
Design N/n Population Sd Interventions Outcomes Results<br />
MA MI -β-blockers<br />
-Placebo<br />
Non-fatal MI RR=0.75 in favour of β-<br />
blockers<br />
www.<strong>farmaka</strong>.be<br />
Project<br />
Farmaka
Change language